Advancing the biology of blood-based Alzheimer's biomarkers, and bringing accurate diagnosis to communities around the world.
OUR VISION
We envision a future where the molecular causes of Alzheimer's disease and related neurodegenerative diseases are fully understood, from brain pathology to cerebrospinal fluid to blood, informing simple, accurate diagnostics available to everyone. Through a network of reference and expert laboratories, from the USA to Africa, we aim to ensure that where a person lives never determines whether they can get a diagnosis or access to treatment.
Leadership
Thomas K. Karikari, PhD
Principal Investigator and Associate Professor of Psychiatry